ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The multicellular tumor spheroid model for high-throughput cancer drug discovery

LaBarbera, Daniel V.*; Reid, Brian G.; Yoo, Byong Hoon
Expert Opinion on Drug Discovery2012-9DOI: 10.1517/17460441.2012.708334
198被引1阅读
引用收藏
分享

摘要

Introduction: For the past 30 years 2D-cell-based assay models have dominated preclinical cancer drug discovery efforts. 2D-cell-based models fail to predict in vivo efficacy, contributing to a lower success rate and higher cost required to translate an investigational new drug to clinical approval. Technological advances in 3D-cell culture models bridge the gap between 2D and in vivo models to improve upon the current success rates of cancer drug discovery. Areas covered: This review focuses on the multicellular tumor spheroid (MCTS), particularly how this model can be utilized for HTS drug discovery. We discuss the current technologies for uniform culture of MCTS suitable for HTS and detection methods utilized for assay development and drug screening. Expert opinion: Substantial hurdles remain before we reach the ultimate goal of robust HTS of large compound libraries with MCTS models. Specifically, we can group these challenges into three categories: MCTS growth, data collection, and data analysis. The MCTS model should be utilized with fluorescent readouts and high-content imaging with a systems biology approach to model human tumors in vitro. Such models will be more predictive of in vivo efficacy, improving on the current success rates of cancer drug discovery from bench to bedside.

学科与关键词

关键词
3D-cultureanticancer drugscell-based assaysdrug discoveryhigh-content screeninghigh-throughput screeningmicroenvironmentspheroid
相关
加载中…
  • Three-dimensional cell culture: the missing link in drug discovery
    Breslin, Susan; O'Driscoll, Lorraine*Drug Discovery Today, 2013, 18(5-6): 240-249.被引 927
  • 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor-on-a-Chip
    Li, Wenxiu; Zhou, Zhihang; Zhou, Xiaoyu; Khoo, Bee Luan; Gunawan, Renardi; Chin, Y. Rebecca; Zhang, Liang; Yi, Changqing; Guan, Xinyuan; Yang, Mengsu*Advanced Healthcare Materials, 2023, 12(18).被引 4
  • IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation
    Xu, Yipeng; Pachnikova, Gabriela; Wang, He; Wu, Yaoyao; Przybilla, Dorothea; Schaefer, Reinhold; Chen, Zihao; Zhu, Shaoxing*; Keilholz, Ulrich*Bosnian Journal of Basic Medical Sciences, 2022, 22(4): 580-592.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Expert Opinion on Drug Discovery
发表日期
2012-09
卷期
第 7 卷, 第 9 期
页码
819-830
DOI
10.1517/17460441.2012.708334
语言
ENGLISH
成果收录
SCIE
资助标注
NIH/NEI [R01 EY021498]; NIH/NIAID pilot grant from GSGADP; Startup funds from Skaggs School of Pharmacy and Pharmaceutical Sciences

作者

  • L

    LaBarbera, Daniel V. (通讯) (第一作者)

  • R

    Reid, Brian G.

查看全部 3 位作者收起作者
  • Y

    Yoo, Byong Hoon

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417